Evidence Based Medicine presented by InpharmD™ podcast

Evidence Based Medicine presented by InpharmD™

InpharmD™

We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.

78 episodios

Ketamine for Sickle Cell Disease
28/8/2024
13:02
InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.
Tirzepatide for Sleep Apnea
26/7/2024
11:02
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the SURMOUNT-OSA clinical trials.
No te pierdas ningún episodio de “Evidence Based Medicine presented by InpharmD™”. Síguelo en la aplicación gratuita de GetPodcast.
Excoriation Disorder
28/5/2024
10:50
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.
Phenytoin for Tacrolimus Toxicity
25/4/2024
14:00
InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.
Atypical Antipsychotics and QT–prolongation
27/2/2024
11:08
InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that’s been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.
Apixaban in Peripheral Artery Disease
30/11/2023
10:30
Join InpharmD as we discuss the role of apixaban in peripheral artery disease.
Safety and Efficacy of RSV Vaccines
27/9/2023
9:59
Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.
Safety and Efficacy of Rezafungin
20/7/2023
9:41
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!
Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction
13/6/2023
8:26
Join InpharmD as we discuss the data on perioperative duloxetine (Cymbalta) during orthopedic surgery for pain reduction. Interested in the full data response? Read here!
Lecanemab in the treatment of Alzheimer’s Dementia
17/4/2023
9:28
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic. Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer’s dementia.

Descubre los mejores podcast en la aplicación gratuita de GetPodcast.

Suscríbete a tus podcast favoritos, escucha episodios cuando estés sin conexión y déjate sorprender por las recomendaciones personalizadas.

© radio.de GmbH 2024